FDA 510(k)

N 抗人免疫球蛋白（IgG、IgA和IgM）抗血清

K号: K233663 · 2023-12-13

申请人Siemens Healthcare Diagnostics Products GmbH

决定日期2023-12-13

产品代码CFN

咨询委员会抱歉，您提供的信息不完整，无法进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics Products GmbH. It received FDA 510(k) clearance on 2023-12-13 under 510(k) number K233663. The device is classified under product code CFN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is a medical device that received FDA 510(k) clearance on 2023-12-13. The listed applicant is Siemens Healthcare Diagnostics Products GmbH. The 510(k) number is K233663.

When did N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) receive FDA 510(k) clearance?

N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) received FDA 510(k) clearance on 2023-12-13, under 510(k) number K233663.

Who is the listed applicant for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

The FDA 510(k) record lists Siemens Healthcare Diagnostics Products GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)?

The FDA product code for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) is CFN.

列明Siemens Healthcare Diagnostics Products GmbH为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K240315INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)K220728vWF抗原 K212559CardioPhase® hsCRP K212379N Latex FLC kappa，N Latex FLC lambda K201496N Latex FLC kappa，N Latex FLC lambda K193047N Latex FLC kappa，N Latex FLC lambda

查看所有 18 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。